Bowel cancer screening is detecting roughly 100 cancers per week among people in their 50s in England, yet participation rates in this age group continue to trail behind older cohorts, according to the latest annual figures published by NHS England.
What the Data Shows
The figures, which cover the 12-month period from April 2024 to March 2025, indicate that just 56.2% of 54-year-olds completed a bowel cancer screening test during that window. Put another way, nearly one in two people at that age did not return a home testing kit — a gap that NHS England has described as a concern given the volume of cancers the programme is already identifying.
Across the broader group of people in their 50s, uptake was similarly below the levels recorded in older age brackets, the data showed. NHS England released the statistics alongside a renewed call for this demographic to complete and return the kits sent to their homes.
Why Uptake Matters at This Age
Bowel cancer is among the most common cancers diagnosed in England, and earlier detection is generally associated with a wider range of treatment options and better clinical outcomes. The fact that screening is already finding approximately 100 cases each week within the 50s age group underscores the scale of undetected disease that may exist among those who have not yet participated.
Screening programmes that rely on home-based testing — in this case, a kit that checks for traces of blood in a stool sample — are designed specifically to reach people before symptoms appear. When participation is incomplete, the programme's ability to identify cancers at an earlier, potentially more treatable stage is correspondingly reduced.
The Broader Screening Picture
NHS England's annual bowel screening data provides a system-wide view of how the programme is performing across different age groups. The 2024–25 figures make clear that the 50s cohort represents a persistent weak point in overall uptake, even as the programme continues to generate a substantial number of positive findings within that same group.
The gap between detection rates and participation levels raises questions about the barriers that may be discouraging people in this age bracket from completing the test. Research in this area has previously pointed to factors including awareness, health literacy, and the perceived inconvenience of home-based stool sampling, though the NHS England release did not detail specific barriers for this cohort.
Context for the Figures
England's bowel cancer screening programme invites eligible individuals by post, sending home testing kits that can be completed without a clinical appointment. The programme has been gradually extended to younger age groups in recent years, meaning that people in their 50s are a relatively newer addition to the eligible population compared with those in their 60s and 70s.
That context may partly explain the lower uptake: awareness of eligibility and familiarity with the process may not yet be as firmly established in the 50s demographic. NHS England's decision to publish these figures prominently suggests an effort to close that awareness gap.
The annual statistics serve as a benchmark for commissioners and public health planners tracking whether the programme is reaching its intended population. With roughly half of one of its youngest eligible age groups not yet participating, the 2024–25 data points to a meaningful opportunity to improve the programme's reach — and, by extension, its capacity to find cancers earlier.